Cargando…

HGG-21. Oncogenic tyrosine kinase gene fusions in infant-type hemispheric gliomas - comparison of RNA- and DNA-based methods for their reliable detection

High-grade diffuse gliomas (HGG) in early childhood are characterized by a more favorable outcome compared to older children. We demonstrated in previous studies that these tumors have stable genomes. Activating tyrosine kinase gene fusions in infant-type hemispheric gliomas represent therapeutic ta...

Descripción completa

Detalles Bibliográficos
Autores principales: Pietsch, Torsten, Gielen, Gerrit, Waha, Andreas, Doerner, Evelyn, von Bueren, Andre O, Vokuhl, Christian, Kristiansen, Glen, Kramm, Christof
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9164882/
http://dx.doi.org/10.1093/neuonc/noac079.236
_version_ 1784720250755874816
author Pietsch, Torsten
Gielen, Gerrit
Waha, Andreas
Doerner, Evelyn
von Bueren, Andre O
Vokuhl, Christian
Kristiansen, Glen
Kramm, Christof
author_facet Pietsch, Torsten
Gielen, Gerrit
Waha, Andreas
Doerner, Evelyn
von Bueren, Andre O
Vokuhl, Christian
Kristiansen, Glen
Kramm, Christof
author_sort Pietsch, Torsten
collection PubMed
description High-grade diffuse gliomas (HGG) in early childhood are characterized by a more favorable outcome compared to older children. We demonstrated in previous studies that these tumors have stable genomes. Activating tyrosine kinase gene fusions in infant-type hemispheric gliomas represent therapeutic targets. 50 supratentorial HGG occurring in children younger than four years were retrieved from the archives of the Brain Tumor Reference Center, Institute of Neuropathology, Bonn University. DNA and RNA were extracted from FFPE tumor samples. Gene fusions were identified on the DNA level by FISH using break-apart probes for ALK, NTRK1, -2, -3, ROS1 and MET and Molecular Inversion Probe (MIP) methodology. On the RNA level, fusion transcripts were detected by targeted RNA sequencing as well as Nanostring assay with fusion-specific probes. 37 supratentorial HGG occurred in the first year of life, 13 HGG between one and four years. 18 cases showed fusions of ALK to different partners; all occurred in the first year of life (18/37, 48.6%). Fusions of ROS1 were found in 5, MET in 3, NTRK1, -2, -3 in 10 cases. 12 cases showed no and two cases novel fusions. The different methods led to comparable results. Only recurrent fusions with known fusion partners were detectable with fusion sequence-specific Nanostring probes and library construction for targeted RNA sequencing failed in a fraction of cases. Break-apart FISH led to reliable results on the next day, and MIP technology represented the most sensitive method for analysis of FFPE samples. Gene fusions involving the tyrosine kinase genes ALK, MET, ROS1 and NTRK1, -2, -3 occurred in 72% of HGG of young children; most frequent were ALK fusions occurring in tumors of infants. DNA-based MIP technology represented the most robust and sensitive assay. A combination of RNA- and DNA-based methods to detect these fusions with high reliability is recommended.
format Online
Article
Text
id pubmed-9164882
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-91648822022-06-05 HGG-21. Oncogenic tyrosine kinase gene fusions in infant-type hemispheric gliomas - comparison of RNA- and DNA-based methods for their reliable detection Pietsch, Torsten Gielen, Gerrit Waha, Andreas Doerner, Evelyn von Bueren, Andre O Vokuhl, Christian Kristiansen, Glen Kramm, Christof Neuro Oncol High Grade Glioma High-grade diffuse gliomas (HGG) in early childhood are characterized by a more favorable outcome compared to older children. We demonstrated in previous studies that these tumors have stable genomes. Activating tyrosine kinase gene fusions in infant-type hemispheric gliomas represent therapeutic targets. 50 supratentorial HGG occurring in children younger than four years were retrieved from the archives of the Brain Tumor Reference Center, Institute of Neuropathology, Bonn University. DNA and RNA were extracted from FFPE tumor samples. Gene fusions were identified on the DNA level by FISH using break-apart probes for ALK, NTRK1, -2, -3, ROS1 and MET and Molecular Inversion Probe (MIP) methodology. On the RNA level, fusion transcripts were detected by targeted RNA sequencing as well as Nanostring assay with fusion-specific probes. 37 supratentorial HGG occurred in the first year of life, 13 HGG between one and four years. 18 cases showed fusions of ALK to different partners; all occurred in the first year of life (18/37, 48.6%). Fusions of ROS1 were found in 5, MET in 3, NTRK1, -2, -3 in 10 cases. 12 cases showed no and two cases novel fusions. The different methods led to comparable results. Only recurrent fusions with known fusion partners were detectable with fusion sequence-specific Nanostring probes and library construction for targeted RNA sequencing failed in a fraction of cases. Break-apart FISH led to reliable results on the next day, and MIP technology represented the most sensitive method for analysis of FFPE samples. Gene fusions involving the tyrosine kinase genes ALK, MET, ROS1 and NTRK1, -2, -3 occurred in 72% of HGG of young children; most frequent were ALK fusions occurring in tumors of infants. DNA-based MIP technology represented the most robust and sensitive assay. A combination of RNA- and DNA-based methods to detect these fusions with high reliability is recommended. Oxford University Press 2022-06-03 /pmc/articles/PMC9164882/ http://dx.doi.org/10.1093/neuonc/noac079.236 Text en © The Author(s) 2022. Published by Oxford University Press on behalf of the Society for Neuro-Oncology. https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial License (https://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle High Grade Glioma
Pietsch, Torsten
Gielen, Gerrit
Waha, Andreas
Doerner, Evelyn
von Bueren, Andre O
Vokuhl, Christian
Kristiansen, Glen
Kramm, Christof
HGG-21. Oncogenic tyrosine kinase gene fusions in infant-type hemispheric gliomas - comparison of RNA- and DNA-based methods for their reliable detection
title HGG-21. Oncogenic tyrosine kinase gene fusions in infant-type hemispheric gliomas - comparison of RNA- and DNA-based methods for their reliable detection
title_full HGG-21. Oncogenic tyrosine kinase gene fusions in infant-type hemispheric gliomas - comparison of RNA- and DNA-based methods for their reliable detection
title_fullStr HGG-21. Oncogenic tyrosine kinase gene fusions in infant-type hemispheric gliomas - comparison of RNA- and DNA-based methods for their reliable detection
title_full_unstemmed HGG-21. Oncogenic tyrosine kinase gene fusions in infant-type hemispheric gliomas - comparison of RNA- and DNA-based methods for their reliable detection
title_short HGG-21. Oncogenic tyrosine kinase gene fusions in infant-type hemispheric gliomas - comparison of RNA- and DNA-based methods for their reliable detection
title_sort hgg-21. oncogenic tyrosine kinase gene fusions in infant-type hemispheric gliomas - comparison of rna- and dna-based methods for their reliable detection
topic High Grade Glioma
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9164882/
http://dx.doi.org/10.1093/neuonc/noac079.236
work_keys_str_mv AT pietschtorsten hgg21oncogenictyrosinekinasegenefusionsininfanttypehemisphericgliomascomparisonofrnaanddnabasedmethodsfortheirreliabledetection
AT gielengerrit hgg21oncogenictyrosinekinasegenefusionsininfanttypehemisphericgliomascomparisonofrnaanddnabasedmethodsfortheirreliabledetection
AT wahaandreas hgg21oncogenictyrosinekinasegenefusionsininfanttypehemisphericgliomascomparisonofrnaanddnabasedmethodsfortheirreliabledetection
AT doernerevelyn hgg21oncogenictyrosinekinasegenefusionsininfanttypehemisphericgliomascomparisonofrnaanddnabasedmethodsfortheirreliabledetection
AT vonbuerenandreo hgg21oncogenictyrosinekinasegenefusionsininfanttypehemisphericgliomascomparisonofrnaanddnabasedmethodsfortheirreliabledetection
AT vokuhlchristian hgg21oncogenictyrosinekinasegenefusionsininfanttypehemisphericgliomascomparisonofrnaanddnabasedmethodsfortheirreliabledetection
AT kristiansenglen hgg21oncogenictyrosinekinasegenefusionsininfanttypehemisphericgliomascomparisonofrnaanddnabasedmethodsfortheirreliabledetection
AT krammchristof hgg21oncogenictyrosinekinasegenefusionsininfanttypehemisphericgliomascomparisonofrnaanddnabasedmethodsfortheirreliabledetection